GlassScriptPhysician profile
Milena Bulic
NPI 1184031130
$2,312.02
in general payments reported to CMS, 2019-2025
7 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.09 · 2020: $269 · 2021: $159 · 2022: $251 · 2023: $1,294 · 2024: $152 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $821 · Food and Beverage: $617 · Gift: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $820.92 |
| Food and Beverage | $616.94 |
| Gift | $166.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,277.15 | 2022-2023 | Invisalign |
| Ormco Corporation | $411.53 | 2019-2023 | Spark |
| World Class Technology Corporation | $333.29 | 2020-2025 | Pitts21, Pitts21 Pro |
| Envista Holdings Corporation | $127.98 | 2024-2025 | Insignia, Spark |
| Purelife, LLC | $75.00 | 2023-2025 | |
| Nobel Biocare USA | $50.31 | 2023 | Nobelactive |
| 3m Company | $36.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milena Bulic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.